ASP Isotopes Inc. Common Stock ASPI
Company coverage
Research activity
ASPI 37 trade records · 16 option records · 2025-10-10 → 2026-05-07Moat
WideProprietary Aerodynamic Separation Process (ASP) maintained as closely guarded trade secret with only 9 authorized individuals permitted access — strategically superior to patents (no public disclosure). 18+ years and tens of millions in R&D investm…
Physical assets
StrongThree commercial enrichment facilities in Pretoria, South Africa — genuinely productive, generating revenue from commercial isotope production (Silicon-28 shipped at 99.995% enrichment). Isotope separation plants are difficult to replicate due to te…
Software / hardware
Growth. Trade-secret enrichment process expands from Silicon-28 (quantum computing substrates) to uranium and lithium isotopes, creating a multi-commodity enrichment platform with near-monopoly pricing. Primary assets. 3 Pretoria enrichment faciliti…
- manual · sw-hw
Growth. Trade-secret enrichment process expands from Silicon-28 (quantum computing substrates) to uranium and lithium isotopes, creating a multi-commodity enrichment platform with near-monopoly pricing. Primary assets. 3 Pretoria…
- manual · physical-assets
Three commercial enrichment facilities in Pretoria, South Africa — genuinely productive, generating revenue from commercial isotope production (Silicon-28 shipped at 99.995% enrichment). Isotope separation plants are difficult to…
- manual · moat
Proprietary Aerodynamic Separation Process (ASP) maintained as closely guarded trade secret with only 9 authorized individuals permitted access — strategically superior to patents (no public disclosure). 18+ years and tens of mil…
| Date | Action | Type | Relative size |
|---|---|---|---|
| 2026-05-07 | SELL | Equity | +100% |
| 2026-05-07 | BUY | CALL option | +1% |
| 2026-05-05 | SELL | Equity | +7% |
| 2026-04-30 | SELL | CALL option | +4% |
| 2026-02-20 | SELL | Equity | +53% |
| 2026-01-28 | SELL | CALL option | +2% |
| 2026-01-26 | BUY | Equity | +47% |
| 2026-01-12 | BUY | CALL option | +11% |
| 2026-01-09 | BUY | Equity | +9% |
| 2026-01-09 | SELL | CALL option | +5% |
| 2026-01-09 | BUY | CALL option | +5% |
| 2026-01-08 | BUY | Equity | +9% |
| 2026-01-07 | BUY | Equity | +2% |
| 2026-01-07 | BUY | Equity | +0% |
| 2026-01-06 | BUY | CALL option | +12% |
| 2026-01-06 | SELL | CALL option | +8% |
| 2026-01-02 | BUY | Equity | +0% |
| 2026-01-02 | SELL | CALL option | +3% |
| 2025-12-23 | SELL | CALL option | +5% |
| 2025-12-23 | BUY | CALL option | +1% |
| 2025-12-22 | BUY | Equity | +2% |
| 2025-12-22 | SELL | CALL option | +2% |
| 2025-12-17 | SELL | CALL option | +2% |
| 2025-12-12 | BUY | PUT option | +6% |
Notes
Full portfolio moat / asset analysis
Proprietary Aerodynamic Separation Process (ASP) maintained as closely guarded trade secret with only 9 authorized individuals permitted access — strategically superior to patents (no public disclosure). 18+ years and tens of millions in R&D investment. Regulatory barriers are substantial: uranium enrichment/isotope separation requires national security app…
Full portfolio moat / asset analysis
Three commercial enrichment facilities in Pretoria, South Africa — genuinely productive, generating revenue from commercial isotope production (Silicon-28 shipped at 99.995% enrichment). Isotope separation plants are difficult to replicate due to technical complexity and regulatory constraints. Additional planned facilities in the UK via Quantum Leap Energy.